In the serum of pancreatic cancer patients, MUC1 levels increase in a stage-dependent manner and so MUC1 expression may be potentially used as biomarker for the diagnosis and staging of PDAC patients. The gene discussed is MUC1; the disease is familial pancreatic carcinoma.